AVR insider trading

Healthcare

Anteris Technologies Global Corp. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
33
Last 90 days
1
Buys / sells
6% / 0%
Market cap
$548.17M

About Anteris Technologies Global Corp.

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Company website: anteristech.com

AVR insider activity at a glance

FilingIQ has scored 33 insider transactions for AVR since Dec 16, 2024. The most recent filing in our index is dated Mar 4, 2026.

Across the full history, 2 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AVR insider trades is 56.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Top insiders trading AVR

13F funds holding AVR

Frequently asked

How many insider trades does FilingIQ track for AVR?
FilingIQ tracks 33 Form 4 insider transactions for AVR (Anteris Technologies Global Corp.), covering filings from Dec 16, 2024 onwards. 1 of those were filed in the last 90 days.
Are AVR insiders net buyers or net sellers?
Across the full Form 4 history for AVR, 2 transactions (6%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AVR insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is AVR in?
Anteris Technologies Global Corp. (AVR) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $548.17M.

Methodology & sources

Every AVR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.